High Intensity Interval Training Leads to Similar Inflammatory Activation As Seen With Traditional Training in Chronic Heart Failure

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Feb 25

PMID 35211515

Authors

Arlana G Taylor

Andrew I Ignaszewski

Shannon S D Bredin

John S Hill

Erin M Shellington

Darren E R Warburton

Affiliations

Soon will be listed here.

Abstract

Background: Inflammatory activation has been associated with the severity and progression of chronic heart failure (CHF). Although cardiac rehabilitation is an important therapy, acute bouts of exercise may lead to increases in pro-inflammatory cytokines with exercise intensity mediating these changes.

Objective: To evaluate the acute inflammatory response in patients living with CHF during a randomized trial following Steady State (SS) or High Intensity Interval (HIIT) training.

Methods: Patients living with CHF ( = 14) were stratified (for body mass and aerobic power) and randomized into SS and HIIT cycle exercise. The HIIT exercise training involved 2 min work:recovery phases at 90:40% heart rate reserve. The SS exercise training involved continuous exercise at 65% of heart rate reserve (matched total work). Acute inflammatory markers were evaluated (via ELISA) at baseline, immediately following the bout, and at 6, 24, and 48 h post-exercise.

Results: There was limited differences in the changes in inflammatory biomarkers across time between the HIIT and SS groups. Both groups experienced a significant ( < 0.05) change in Interleukin-6 immediately post-exercise.

Conclusions: A single bout of HIIT or SS does not result in excessive inflammatory activation in CHF patients. Acute HIIT and SS result in similar changes in inflammatory markers. These findings have important implications for exercise training and rehabilitation programs in persons living with CHF.

References

Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M . Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol. 2005; 100(1):93-9. DOI: 10.1016/j.ijcard.2004.08.073. View

Pedersen B, Steensberg A, Fischer C, Keller C, Ostrowski K, Schjerling P . Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev. 2001; 7:18-31. View

Koshikawa M, Harada M, Noyama S, Kiyono K, Motoike Y, Nomura Y . Association between inflammation and skeletal muscle proteolysis, skeletal mass and strength in elderly heart failure patients and their prognostic implications. BMC Cardiovasc Disord. 2020; 20(1):228. PMC: 7229573. DOI: 10.1186/s12872-020-01514-0. View

Peake J, Suzuki K, Hordern M, Wilson G, Nosaka K, Coombes J . Plasma cytokine changes in relation to exercise intensity and muscle damage. Eur J Appl Physiol. 2005; 95(5-6):514-21. DOI: 10.1007/s00421-005-0035-2. View

Ostrowski K, Schjerling P, Pedersen B . Physical activity and plasma interleukin-6 in humans--effect of intensity of exercise. Eur J Appl Physiol. 2001; 83(6):512-5. DOI: 10.1007/s004210000312. View

Pedersen B, Febbraio M . Muscle-derived interleukin-6--a possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav Immun. 2005; 19(5):371-6. DOI: 10.1016/j.bbi.2005.04.008. View

Stone J, Arthur H . Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention, second edition, 2004: executive summary. Can J Cardiol. 2005; 21 Suppl D:3D-19D. View

Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zamboni M . Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol. 2001; 37(8):2080-5. DOI: 10.1016/s0735-1097(01)01306-7. View

Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Ferrer J . Prognostic value of interleukin-8 as a predictor of heart failure in patients with myocardial infarction and percutaneous intervention. Int J Cardiol. 2005; 111(1):158-60. DOI: 10.1016/j.ijcard.2005.05.063. View

10.

Bruunsgaard H, Pedersen B . Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am. 2003; 23(1):15-39. DOI: 10.1016/s0889-8561(02)00056-5. View

11.

March D, Lai K, Neal T, Graham-Brown M, Highton P, Churchward D . Circulating endotoxin and inflammation: associations with fitness, physical activity and the effect of a 6-month programme of cycling exercise during haemodialysis. Nephrol Dial Transplant. 2021; 37(2):366-374. DOI: 10.1093/ndt/gfab178. View

12.

Modur V, Li Y, Zimmerman G, Prescott S, McIntyre T . Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest. 1998; 100(11):2752-6. PMC: 508479. DOI: 10.1172/JCI119821. View

13.

Yin W, Chen J, Jen H, Chiang M, Huang W, Feng A . Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J. 2004; 147(5):931-8. DOI: 10.1016/j.ahj.2003.11.021. View

14.

Saitoh M, Santos M, Emami A, Ishida J, Ebner N, Valentova M . Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). ESC Heart Fail. 2017; 4(4):448-457. PMC: 5695184. DOI: 10.1002/ehf2.12209. View

15.

Nielsen H, Oktedalen O, Opstad P, Lyberg T . Plasma Cytokine Profiles in Long-Term Strenuous Exercise. J Sports Med (Hindawi Publ Corp). 2016; 2016:7186137. PMC: 4864530. DOI: 10.1155/2016/7186137. View

16.

Rauch B, Salzwedel A, Bjarnason-Wehrens B, Albus C, Meng K, Schmid J . Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 1. J Clin Med. 2021; 10(10). PMC: 8161282. DOI: 10.3390/jcm10102192. View

17.

Kinugawa T, Kato M, Ogino K, Igawa O, Hisatome I, Shigemasa C . Neurohormonal determinants of peak oxygen uptake in patients with chronic heart failure. Jpn Heart J. 2003; 44(5):725-34. DOI: 10.1536/jhj.44.725. View

18.

Murphy E, Enos R, Velazquez K . Influence of Exercise on Inflammation in Cancer: Direct Effect or Innocent Bystander?. Exerc Sport Sci Rev. 2015; 43(3):134-42. DOI: 10.1249/JES.0000000000000054. View

19.

Anand I, Latini R, Florea V, Kuskowski M, Rector T, Masson S . C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation. 2005; 112(10):1428-34. DOI: 10.1161/CIRCULATIONAHA.104.508465. View

20.

Larsen A, Aukrust P, Aarsland T, Dickstein K . Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure. Am J Cardiol. 2001; 88(7):805-8. DOI: 10.1016/s0002-9149(01)01859-8. View